Targacept, Inc. (TRGT) to Report Third Quarter 2012 Financial Results on November 6, 2012  
11/1/2012 8:54:03 AM

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™ , today announced that it will report financial results for the third quarter of 2012 on Tuesday, November 6, 2012, after the U.S. financial markets close.